304 related articles for article (PubMed ID: 11076521)
1. Oxidation of indole by cytochrome P450 enzymes.
Gillam EM; Notley LM; Cai H; De Voss JJ; Guengerich FP
Biochemistry; 2000 Nov; 39(45):13817-24. PubMed ID: 11076521
[TBL] [Abstract][Full Text] [Related]
2. Formation of indigo by recombinant mammalian cytochrome P450.
Gillam EM; Aguinaldo AM; Notley LM; Kim D; Mundkowski RG; Volkov AA; Arnold FH; Soucek P; DeVoss JJ; Guengerich FP
Biochem Biophys Res Commun; 1999 Nov; 265(2):469-72. PubMed ID: 10558891
[TBL] [Abstract][Full Text] [Related]
3. Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process.
Sun H; Ehlhardt WJ; Kulanthaivel P; Lanza DL; Reilly CA; Yost GS
J Pharmacol Exp Ther; 2007 Aug; 322(2):843-51. PubMed ID: 17502430
[TBL] [Abstract][Full Text] [Related]
4. Random mutagenesis of human cytochrome p450 2A6 and screening with indole oxidation products.
Nakamura K; Martin MV; Guengerich FP
Arch Biochem Biophys; 2001 Nov; 395(1):25-31. PubMed ID: 11673862
[TBL] [Abstract][Full Text] [Related]
5. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
6. Genotoxic activation of benzophenone and its two metabolites by human cytochrome P450s in SOS/umu assay.
Takemoto K; Yamazaki H; Nakajima M; Yokoi T
Mutat Res; 2002 Aug; 519(1-2):199-204. PubMed ID: 12160905
[TBL] [Abstract][Full Text] [Related]
7. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.
Duescher RJ; Elfarra AA
Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896
[TBL] [Abstract][Full Text] [Related]
8. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
9. Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis.
Guengerich FP; Sorrells JL; Schmitt S; Krauser JA; Aryal P; Meijer L
J Med Chem; 2004 Jun; 47(12):3236-41. PubMed ID: 15163202
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6.
Wu ZL; Aryal P; Lozach O; Meijer L; Guengerich FP
Chem Biodivers; 2005 Jan; 2(1):51-65. PubMed ID: 17191919
[TBL] [Abstract][Full Text] [Related]
11. Exploiting the versatility of human cytochrome P450 enzymes: the promise of blue roses from biotechnology.
Gillam EM; Guengerich FP
IUBMB Life; 2001 Dec; 52(6):271-7. PubMed ID: 11895075
[TBL] [Abstract][Full Text] [Related]
12. Mutations of toluene-4-monooxygenase that alter regiospecificity of indole oxidation and lead to production of novel indigoid pigments.
McClay K; Boss C; Keresztes I; Steffan RJ
Appl Environ Microbiol; 2005 Sep; 71(9):5476-83. PubMed ID: 16151140
[TBL] [Abstract][Full Text] [Related]
13. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of P450 BM3 and glucose dehydrogenase by recombinant Escherichia coli and its application in an NADPH-dependent indigo production system.
Lu Y; Mei L
J Ind Microbiol Biotechnol; 2007 Mar; 34(3):247-53. PubMed ID: 17171348
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains.
Helvig C; Capdevila JH
Biochemistry; 2000 May; 39(17):5196-205. PubMed ID: 10819987
[TBL] [Abstract][Full Text] [Related]
17. Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesis.
Wu ZL; Podust LM; Guengerich FP
J Biol Chem; 2005 Dec; 280(49):41090-100. PubMed ID: 16215230
[TBL] [Abstract][Full Text] [Related]
18. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
19. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
20. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]